{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:16:48Z","timestamp":1775740608486,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01361-2","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:19:20Z","timestamp":1764062360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Local Recurrence Rates in Locally Advanced Rectal Cancer Are Higher with KRAS Codon 13 Mutations"],"prefix":"10.1007","volume":"56","author":[{"given":"Richard","family":"Sassun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaclara","family":"Sileo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyi Cheng","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Aboelmaaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim A.","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Mari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie L.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Dozois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"1361_CR1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/CODI.15698","volume":"23","author":"MR Fahy","year":"2021","unstructured":"Fahy MR, Kelly ME, Power Foley M, Nugent TS, Shields CJ, Winter DC. The role of intraoperative radiotherapy in advanced rectal cancer: a meta-analysis. Colorectal Dis. 2021;23:1998\u20132006. https:\/\/doi.org\/10.1111\/CODI.15698.","journal-title":"Colorectal Dis"},{"key":"1361_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1245\/S10434-022-12564-3","volume":"30","author":"M Arshad","year":"2023","unstructured":"Arshad M, Al-Hallaq H, Polite BN, Shogan BD, Hyman N, Liauw SL. Intra-operative radiation therapy for colorectal or anal cancer at risk for margin-positive resection: initial results of a single-institution registry. Ann Surg Oncol. 2023;30:325\u201332. https:\/\/doi.org\/10.1245\/S10434-022-12564-3.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1361_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJSO.2025.110181","volume":"51","author":"JC Ng","year":"2025","unstructured":"Ng JC, Sassun R, Sileo A, Violante T, Brady JT, DeLeon MF, et al. Real-world clinical outcomes of total neoadjuvant therapy followed by total mesorectal excision for locally advanced rectal cancer at a high-volume institution. Eur J Surg Oncol. 2025;110181. https:\/\/doi.org\/10.1016\/J.EJSO.2025.110181.","journal-title":"Eur J Surg Oncol"},{"key":"1361_CR4","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1080\/0284186X.2023.2269644","volume":"62","author":"PE Storli","year":"2023","unstructured":"Storli PE, Dille-Amdam RG, Skj\u00e6rseth GH, Gran MV, Myklebust T\u00c5, Gr\u00f8nbech JE, et al. Cumulative incidence of first recurrence after curative treatment of stage I-III colorectal cancer. Competing risk analyses of temporal and anatomic patterns. Acta Oncol. 2023;62:1822\u201330. https:\/\/doi.org\/10.1080\/0284186X.2023.2269644.","journal-title":"Acta Oncol"},{"key":"1361_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/SLA.0000000000003002","volume":"269","author":"J Fleshman","year":"2019","unstructured":"Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg. 2019;269:589\u201395. https:\/\/doi.org\/10.1097\/SLA.0000000000003002.","journal-title":"Ann Surg"},{"key":"1361_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/DCR.0000000000001762","volume":"63","author":"YN You","year":"2020","unstructured":"You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum. 2020;63:1191\u2013222. https:\/\/doi.org\/10.1097\/DCR.0000000000001762.","journal-title":"Dis Colon Rectum"},{"key":"1361_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002990","author":"JS Park","year":"2016","unstructured":"Park JS, Sakai Y, Simon NSM, Law WL, Kim HR, Oh JH, et al. Long-term survival and local relapse following surgery without radiotherapy for locally advanced upper rectal cancer: an international multi-institutional study. Medicine (Baltimore). 2016. https:\/\/doi.org\/10.1097\/MD.0000000000002990.","journal-title":"Medicine (Baltimore)"},{"key":"1361_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/JGO.2017.06.07","volume":"8","author":"CC Fossum","year":"2017","unstructured":"Fossum CC, Alabbad JY, Romak LB, Hallemeier CL, Haddock MG, Huebner M, et al. The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis. J Gastrointest Oncol. 2017;8:650. https:\/\/doi.org\/10.21037\/JGO.2017.06.07.","journal-title":"J Gastrointest Oncol"},{"key":"1361_CR9","doi-asserted-by":"publisher","DOI":"10.1245\/S10434-025-16962-1","author":"JC Ng","year":"2025","unstructured":"Ng JC, Sileo A, Sassun R, Aboelmaaty S, Violante T, Gomaa IA, et al. Predictors of pathologic non-response to neoadjuvant approaches in locally advanced rectal cancer. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/S10434-025-16962-1.","journal-title":"Ann Surg Oncol"},{"key":"1361_CR10","doi-asserted-by":"publisher","unstructured":"Glimelius B, Tiret E, Cervantes A, Arnold D. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24. https:\/\/doi.org\/10.1093\/ANNONC\/MDT240. Suppl 6.","DOI":"10.1093\/ANNONC\/MDT240"},{"key":"1361_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2025.102206","volume":"29","author":"IA Gomaa","year":"2025","unstructured":"Gomaa IA, Aboelmaaty S, Sassun R, Sileo A, Ng JC, Keshk NO, et al. Downstaged lateral pelvic lymph nodes require no resection after neoadjuvant therapy and total mesorectal excision. J Gastrointest Surg. 2025;29:102206. https:\/\/doi.org\/10.1016\/j.gassur.2025.102206.","journal-title":"J Gastrointest Surg"},{"key":"1361_CR12","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1245\/S10434-016-5205-4","volume":"23","author":"OS Chow","year":"2016","unstructured":"Chow OS, Kuk D, Keskin M, Smith JJ, Camacho N, Pelossof R, et al. KRAS and combined KRAS\/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy. Ann Surg Oncol. 2016;23:2548\u201355. https:\/\/doi.org\/10.1245\/S10434-016-5205-4.","journal-title":"Ann Surg Oncol"},{"key":"1361_CR13","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1245\/S10434-013-2910-0","volume":"20","author":"MP Duldulao","year":"2013","unstructured":"Duldulao MP, Lee W, Nelson RA, Li W, Chen Z, Kim J, et al. Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma. Ann Surg Oncol. 2013;20:2166\u201371. https:\/\/doi.org\/10.1245\/S10434-013-2910-0.","journal-title":"Ann Surg Oncol"},{"key":"1361_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/HIS.14710","volume":"81","author":"M Swets","year":"2022","unstructured":"Swets M, Graham Martinez C, van Vliet S, van Tilburg A, Gelderblom H, Marijnen CAM, et al. Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature. Histopathology. 2022;81:352\u201362. https:\/\/doi.org\/10.1111\/HIS.14710.","journal-title":"Histopathology"},{"key":"1361_CR15","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1158\/1078-0432.CCR-09-1165","volume":"15","author":"Y He","year":"2009","unstructured":"He Y, Van\u2019t Veer LJ, Mikolajewska-Hanclich I, Van Velthuysen MLF, Zeestraten ECM, Nagtegaal ID, et al. PIK3CA mutations predict local recurrences in rectal cancer patients. Clin Cancer Res. 2009;15:6956\u201362. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1165.","journal-title":"Clin Cancer Res"},{"key":"1361_CR16","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1002\/IJC.28619","volume":"134","author":"MRJ Kohonen-Corish","year":"2014","unstructured":"Kohonen-Corish MRJ, Tseung J, Chan C, Currey N, Dent OF, Clarke S, et al. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. Int J Cancer. 2014;134:2820\u20138. https:\/\/doi.org\/10.1002\/IJC.28619.","journal-title":"Int J Cancer"},{"key":"1361_CR17","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/SJA.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13:S31\u20134. https:\/\/doi.org\/10.4103\/SJA.SJA_543_18.","journal-title":"Saudi J Anaesth"},{"key":"1361_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/JNCCN.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:1139\u201367. https:\/\/doi.org\/10.6004\/JNCCN.2022.0051.","journal-title":"J Natl Compr Canc Netw"},{"key":"1361_CR19","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1245\/S10434-023-13141-Y","volume":"30","author":"H Swartjes","year":"2023","unstructured":"Swartjes H, van Rees JM, van Erning FN, Verheij M, Verhoef C, de Wilt JHW, et al. Locally recurrent rectal cancer: toward a second chance at cure? A population-based, retrospective cohort study. Ann Surg Oncol. 2023;30:3915\u201324. https:\/\/doi.org\/10.1245\/S10434-023-13141-Y.","journal-title":"Ann Surg Oncol"},{"key":"1361_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/BJS\/ZNAF034","author":"JC Ng","year":"2025","unstructured":"Ng JC, Sassun R, Sileo A, Perry WRG, Mathis KL, Larson DW. Pathological staging predicts survival more accurately than clinical staging in locally advanced rectal cancer following total neoadjuvant therapy. Br J Surg. 2025. https:\/\/doi.org\/10.1093\/BJS\/ZNAF034.","journal-title":"Br J Surg"},{"key":"1361_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/DCR.0B013E3181CF8841","volume":"53","author":"E Syk","year":"2010","unstructured":"Syk E, Glimelius B, Nilsson PJ. Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series. Dis Colon Rectum. 2010;53:744\u201352. https:\/\/doi.org\/10.1007\/DCR.0B013E3181CF8841.","journal-title":"Dis Colon Rectum"},{"key":"1361_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2023.1272808","author":"Z Xu","year":"2024","unstructured":"Xu Z, Bao M, Cai Q, Wang Q, Xing W, Liu Q. Optimization of treatment strategies based on preoperative imaging features and local recurrence areas for locally advanced lower rectal cancer after lateral pelvic lymph node dissection. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/FONC.2023.1272808.","journal-title":"Front Oncol"},{"key":"1361_CR23","doi-asserted-by":"publisher","DOI":"10.1245\/S10434-024-16773-W","author":"A Sileo","year":"2025","unstructured":"Sileo A, Sassun R, Ng JC, Aboelmaaty S, Gomaa IA, Mari G, et al. Age matters: early-onset rectal cancer exhibits higher rates of pathological complete response: a retrospective analysis of the influence of young age on treatment success in stage II-III rectal cancer. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/S10434-024-16773-W.","journal-title":"Ann Surg Oncol"},{"key":"1361_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/J.RADONC.2009.10.001","volume":"94","author":"J Gaedcke","year":"2010","unstructured":"Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, et al. KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. Radiother Oncol. 2010;94:76\u201381. https:\/\/doi.org\/10.1016\/J.RADONC.2009.10.001.","journal-title":"Radiother Oncol"},{"key":"1361_CR25","doi-asserted-by":"publisher","first-page":"7326","DOI":"10.1245\/S10434-025-17804-W","volume":"32","author":"S Aboelmaaty","year":"2025","unstructured":"Aboelmaaty S, Gomaa IA, Sileo A, Sassun R, Ng JC, Keshk NO, et al. The impact of RAS\/BRAF mutation on pathological complete response after total neoadjuvant therapy in rectal cancer. Ann Surg Oncol. 2025;32:7326\u201332. https:\/\/doi.org\/10.1245\/S10434-025-17804-W.","journal-title":"Ann Surg Oncol"},{"key":"1361_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/JSO.26244","volume":"123","author":"P Zhou","year":"2021","unstructured":"Zhou P, Goffredo P, Ginader T, Thompson D, Hrabe J, Gribovskaja-Rupp I, et al. Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer. J Surg Oncol. 2021;123:278\u201385. https:\/\/doi.org\/10.1002\/JSO.26244.","journal-title":"J Surg Oncol"},{"key":"1361_CR27","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/J.HPB.2019.03.368","volume":"21","author":"GA Margonis","year":"2019","unstructured":"Margonis GA, Amini N, Andreatos N, Sasaki K, McVey J, Mirza MB, et al. KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases. HPB (Oxford). 2019;21:1527\u201334. https:\/\/doi.org\/10.1016\/J.HPB.2019.03.368.","journal-title":"HPB (Oxford)"},{"key":"1361_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/JTO.0000000000000432","volume":"10","author":"HA Yu","year":"2015","unstructured":"Yu HA, Sima CS, Shen R, Kass S, Gainor J, Shaw A, et al. Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas. J Thorac Oncol. 2015;10:431\u20137. https:\/\/doi.org\/10.1097\/JTO.0000000000000432.","journal-title":"J Thorac Oncol"},{"key":"1361_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MPA.0000000000000077","volume":"43","author":"BV Sinn","year":"2014","unstructured":"Sinn BV, Striefler JK, Rudl MA, Lehmann A, Bahra M, Denkert C, et al. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma. Pancreas. 2014;43:578\u201383. https:\/\/doi.org\/10.1097\/MPA.0000000000000077.","journal-title":"Pancreas"},{"key":"1361_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/S12957-023-03136-0","author":"R Okamura","year":"2023","unstructured":"Okamura R, Itatani Y, Fujita Y, Hoshino N, Okumura S, Nishiyama K, et al. Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern? World J Surg Oncol. 2023. https:\/\/doi.org\/10.1186\/S12957-023-03136-0.","journal-title":"World J Surg Oncol"},{"key":"1361_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/S00384-015-2182-1","volume":"30","author":"M R\u00e4s\u00e4nen","year":"2015","unstructured":"R\u00e4s\u00e4nen M, Carpelan-Holmstr\u00f6m M, Mustonen H, Renkonen-Sinisalo L, Lepist\u00f6 A. Pattern of rectal cancer recurrence after curative surgery. Int J Colorectal Dis. 2015;30:775\u201385. https:\/\/doi.org\/10.1007\/S00384-015-2182-1.","journal-title":"Int J Colorectal Dis"},{"key":"1361_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3748\/WJG.V4.I6.527","volume":"4","author":"HY Yuan","year":"1998","unstructured":"Yuan HY, Li Y, Yang GL, Bei DJ, Wang K. Study on the causes of local recurrence of rectal cancer after curative resection: analysis of 213 cases. World J Gastroenterol. 1998;4:527\u20139. https:\/\/doi.org\/10.3748\/WJG.V4.I6.527.","journal-title":"World J Gastroenterol"},{"key":"1361_CR33","doi-asserted-by":"publisher","unstructured":"Sassun R, Sileo A, Mari G, Mathis KL, Dozois EJ, Larson DW. Mutations in codon 13 of KRAS influence local recurrences in stage III rectal cancer. J Gastrointest Surg. 2024;29. https:\/\/doi.org\/10.1016\/j.gassur.2024.10.029.","DOI":"10.1016\/j.gassur.2024.10.029"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01361-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01361-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01361-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:19:20Z","timestamp":1764062360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01361-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1361"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01361-2","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"18 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board (22-004896).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"228"}}